Federal Register of Legislation - Australian Government

Primary content

This instrument is a notification that the Minister's delegate has exercised discretion under subsection 99ACF(3AA) of the National Health Act 1953 to not apply a first new brand statutory price reduction that would otherwise apply to the specified drugs on 1 April 2020.
Administered by: Health and Aged Care
Registered 31 Mar 2020
Help with file formats Help with file formats
Notifiable Instrument
 
F2020N00037 : Authoritative PDF Document : 0.6MB Primary Document Icon F2020N00037 : ZIP Document : 57KB
3 pages